Total Payments
$23,119
2024 Payments
$3,014
Companies
52
Transactions
1,041
Medicare Patients
22,662
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$19,315 (83.5%)
Consulting$3,523 (15.2%)
Education$281.69 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,315 | 1,033 | 83.5% |
| Consulting Fee | $3,523 | 3 | 15.2% |
| Education | $281.69 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $3,173 | 78 | $0 (2024) |
| ABBVIE INC. | $2,452 | 125 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $2,373 | 46 | $0 (2024) |
| Janssen Biotech, Inc. | $2,013 | 128 | $0 (2024) |
| PFIZER INC. | $1,525 | 84 | $0 (2024) |
| Lilly USA, LLC | $1,251 | 51 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,134 | 60 | $0 (2024) |
| Amgen Inc. | $1,061 | 57 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $879.73 | 31 | $0 (2024) |
| MAYNE PHARMA INC. | $780.68 | 60 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,014 | 144 | UCB, Inc. ($427.01) |
| 2023 | $2,876 | 139 | Janssen Biotech, Inc. ($396.88) |
| 2022 | $2,568 | 123 | Janssen Biotech, Inc. ($331.19) |
| 2021 | $1,643 | 87 | Janssen Biotech, Inc. ($277.51) |
| 2020 | $2,558 | 47 | UCB, Inc. ($1,659) |
| 2019 | $5,143 | 174 | Ortho Dermatologics, a division of Bausch Health US, LLC ($2,069) |
| 2018 | $3,077 | 177 | PFIZER INC. ($613.60) |
| 2017 | $2,240 | 150 | AbbVie, Inc. ($259.57) |
All Payment Transactions
1,041 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Inflammation & Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.69 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.28 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.98 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.77 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.10 | General |
| Category: Immunology | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Inflammation & Immunology | ||||||
| 11/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: ANTIBIOTIC | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: Immunology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.63 | General |
| Category: Immunology | ||||||
| 10/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology | ||||||
| 10/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.01 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.24 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 5,883 | 11,450 | $1.3M | $418,484 |
| 2022 | 23 | 5,734 | 11,169 | $1.2M | $395,002 |
| 2021 | 24 | 5,733 | 10,287 | $1.3M | $436,714 |
| 2020 | 24 | 5,312 | 9,456 | $1.2M | $377,457 |
Total Patients
22,662
Total Services
42,362
Medicare Billing
$1.6M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 637 | 889 | $158,836 | $54,196 | 34.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,068 | 1,298 | $172,971 | $48,608 | 28.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 962 | 1,179 | $131,635 | $44,239 | 33.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 495 | 549 | $124,130 | $43,740 | 35.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 487 | 572 | $115,867 | $38,233 | 33.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 146 | 166 | $100,628 | $37,482 | 37.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 929 | 5,502 | $73,299 | $27,061 | 36.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 168 | 201 | $67,793 | $24,744 | 36.5% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 68 | 77 | $48,618 | $17,926 | 36.9% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 44 | 49 | $30,480 | $11,771 | 38.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 231 | 231 | $33,112 | $10,519 | 31.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 100 | 110 | $53,579 | $10,514 | 19.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 136 | 136 | $30,147 | $10,209 | 33.9% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 54 | 61 | $32,592 | $6,076 | 18.6% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 52 | 58 | $29,288 | $5,745 | 19.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 90 | 126 | $12,659 | $4,936 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 57 | $14,400 | $4,701 | 32.6% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 19 | 21 | $11,958 | $4,241 | 35.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 44 | 44 | $11,066 | $3,845 | 34.7% |
| 11641 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 35 | 36 | $17,035 | $3,310 | 19.4% |
| 69100 | Biopsy of ear | Office | 2023 | 41 | 48 | $9,227 | $2,749 | 29.8% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 12 | 12 | $4,265 | $1,524 | 35.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 14 | 15 | $3,780 | $1,236 | 32.7% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $4,480 | $878.10 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 617 | 867 | $156,251 | $53,560 | 34.3% |
About Dr. Mohammed Chaker, M.D
Dr. Mohammed Chaker, M.D is a Dermatology healthcare provider based in Burleson, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417054719.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Chaker, M.D has received a total of $23,119 in payments from pharmaceutical and medical device companies, with $3,014 received in 2024. These payments were reported across 1,041 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($19,315).
As a Medicare-enrolled provider, Chaker has provided services to 22,662 Medicare beneficiaries, totaling 42,362 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Burleson, TX
- Active Since 09/20/2006
- Last Updated 03/26/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417054719
Products in Payments
- SILIQ (Drug) $2,027
- EUCRISA (Drug) $1,454
- DUPIXENT (Biological) $1,375
- Cimzia (Drug) $1,102
- Otezla (Drug) $970.88
- TALTZ (Drug) $918.18
- TREMFYA (Drug) $900.86
- Humira (Biological) $832.25
- COSENTYX (Biological) $825.66
- SKYRIZI (Biological) $756.39
- DORYX (Drug) $601.67
- ADBRY (Biological) $582.38
- REMICADE (Biological) $568.01
- Sotyktu (Drug) $529.06
- Bimzelx (Biological) $448.78
- RINVOQ (Biological) $417.25
- Tremfya (Drug) $399.31
- Enbrel (Biological) $357.25
- STELARA (Biological) $271.94
- COSENTYX (Drug) $265.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.